Xingui Xiong

Xingui Xiong


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
HZHao Zhu
Hao Zhu
QLQing-Hua Liang
Qing-Hua Liang
XXXingui Xiong
Xingui Xiong
YWYang Wang
Yang Wang
ZZZhi-Hui Zhang
Zhi-Hui Zhang
DWDan Wu
Dan Wu
Objectives. In China, Oldenlandia diffusa (OD) is a natural herb that is widely used and has been proven to be effective in the treatment of rheumatoid arthritis (RA). This study aimed to preliminarily reveal the mechanism by which OD exerts its beneficial effect. Methods. Ultra‐performance liquid chromatography photodiode array was applied to identify the absorbable compounds in the plasma of collagen‐induced arthritis (CIA) model rats. After 2 weeks, an OD decoction or the identified absorbable compound was administered to CIA rats. Morphology, X‐ray images of the joints, pathological images, arthritis index, and cytokine (TNF‐α and IL‐6) levels were evaluated. Results. p‐Coumaric acid (p‐CA) was identified as the absorbed compound in plasma. After administration of p‐CA solution or the OD decoction, symptoms in the treated rats were alleviated as compared to the untreated model rats, and inflammatory cell infiltration was suppressed. The arthritis index and serum levels of TNF‐α and IL‐6 were decreased as compared to the control group. Conclusions. OD may exert its anti‐inflammatory effect on RA via its active ingredient, p‐CA. This information sheds light on the mechanism by which OD exerts its anti‐inflammatory effort in RA and forms the basis for further development of therapeutic agents for RA.

1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HZHao Zhu
Hao Zhu
QLQing-Hua Liang
Qing-Hua Liang
XXXingui Xiong
Xingui Xiong
JCJiang Chen
Jiang Chen
DWDan Wu
Dan Wu
XHXi Huang
Xi Huang
Objectives. This study aimed to identify the active compounds in Oldenlandia diffusa (OD) decoction and the compounds absorbed into plasma, and to determine whether the absorbed compounds derived from OD exerted any anti‐inflammatory effects in rats with collagen induced arthritis (CIA). Methods. The UPLC‐PDA (Ultra Performance Liquid Chromatography Photo‐Diode Array) method was applied to identify the active compounds both in the decoction and rat plasma. The absorbable compound was administered to the CIA rats, and the effects were dynamically observed. X‐ray films of the joints and HE stain of synovial tissues were analyzed. The levels of IL‐1β and TNF‐α in the rats from each group were measured by means of ELISA. The absorbed compound in the plasma of CIA rats was identified as ferulic acid (FA), following OD decoction administration. Two weeks after the administration of FA solution or OD decoction, the general conditions improved compared to the model group. The anti‐inflammatory effect of FA was inferior to that of the OD decoction (P < 0.05), based on a comparison of IL‐1β TNF‐α levels. FA from the OD decoction was absorbed into the body of CIA rats, where it elicited anti‐inflammatory responses in rats with CIA. Conclusions. These results suggest that FA is the bioactive compound in OD decoction, and FA exerts its effects through anti‐inflammatory pathways.

23 October 2013 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
DWDan Wu
Dan Wu
JCJiang Chen
Jiang Chen
HZHao Zhu
Hao Zhu
XXXingui Xiong
Xingui Xiong
QLQing-Hua Liang
Qing-Hua Liang
XHXi Huang
Xi Huang
Rheumatoid arthritis (RA) is a chronic disabling autoimmune disease with characteristics of chronic, progressive inflammatory joint synovial damage, which mainly encroaches upon the synovium of the joint. The use of traditional medicine to treat RA slows the development of RA to a certain extent; however, it often has numerous side‑effects. Therefore, the focus of RA research is the identification of a new, safe and effective medicine. The aim of the present study was to use an ultra performance liquid chromatography and photo diode array (UPLC‑PDA) method to detect the paeoniflorin component in a Radix Paeoniae Alba decoction and in rat plasma following the oral administration of Radix Paeoniae Alba decoction. In addition, the effects of paeoniflorin on collagen‑induced arthritis (CIA) in rats were investigated. The results indicate that a UPLC‑PDA method for determining the presence of paeoniflorin in the Radix Paeoniae Alba decoction was successfully established. The method was fast, simple, sensitive, precise and valid. Paeoniflorin was shown to be a bioactive component of the Radix Paeoniae Alba decoction that was absorbed into rat plasma. Paeoniflorin significantly improved the disease resistant ability of RA rats and reduced the levels of the inflammatory cytokines, IL‑1β and TNF‑α, thereby inhibiting inflammation and bone erosion in the rats with CIA. The observations are likely to lay the foundation for further study of the mechanism of paeoniflorin in the treatment of RA.

1 March 2018 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
SYShu Yang
Shu Yang
ZXZhihua Xing
Zhihua Xing
TLTao Liu
Tao Liu
JZJing Zhou
Jing Zhou
QLQinghua Liang
Qinghua Liang
YWYang Wang
Yang Wang
Background: Rheumatoid arthritis (RA) is a common worldwide public health problem, which causes a chronic, systemic inflammatory disorder of synovial joints. Paeoniflorin (PA) has achieved positive results to some extent for the treatment of RA. Purpose: This study aimed to reveal the potential druggable targets of PA in an experimental RA model using quantitative proteomics analysis. Study design and methods: Thirty Sprague-Dawley rats were randomly divided into a normal group, model group and PA group. PA (1 mg/kg) was used to treat collagen-induced arthritis (CIA) rats for 42 days. We used isobaric tags for relative and absolute quantitation-based quantitative proteomics to analyze the synovial tissue of rats. Ingenuity pathway analysis (IPA) software was applied to process the data. The proteins that were targeted via IPA software were verified by Western blots. Results: We found that PA caused 86 differentially expressed proteins (≥1.2-fold or ≤0.84-fold) compared with the CIA group. Of these varied proteins, 20 significantly changed (p<0.05) proteins referred to 41 CIA-relative top pathways after IPA pathway analysis. Thirteen of the PA-regulated pathways were anchored, which intervened in 24 biological functions. Next, network analysis revealed that leukemia inhibitory factor receptor (LIFR) and asporin (ASPN), which participate in two significant networks, contributed the most to the efficacy of PA treatment. Additionally, Western blots confirmed the aforementioned druggable targets of PA for the treatment of RA. Conclusion: The results reveal that PA may treat RA by decreasing two key proteins, LIFR and ASPN. Our research helps to identify potential agents for RA treatment.

1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XXXingui Xiong
Xingui Xiong
QLQinghua Liang
Qinghua Liang
CZChunhu Zhang
Chunhu Zhang
YWYang Wang
Yang Wang
WHWei Huang
Wei Huang
ZXZhihua Xing
Zhihua Xing
Background. Cognitive impairment is the leading cause of traumatic brain injury- (TBI-) related disability; however, the underlying pathogenesis of this dysfunction is not completely understood. Methods. Using an isobaric tagging for relative and absolute quantitation- (iTRAQ-) based quantitative proteomic approach, serum samples from healthy control subjects, TBI patients with cognitive impairment, and TBI patients without cognitive impairment were analysed to identify differentially expressed proteins (DEPs) related to post-TBI cognitive impairment. In addition, DEPs were further analysed using bioinformatic platforms and validated using enzyme-linked immunosorbent assays (ELISA). Results. A total of 56 DEPs were identified that were specifically related to TBI-induced cognitive impairment. Bioinformatic analysis revealed that a wide variety of cellular and metabolic processes and some signaling pathways were involved in the pathophysiology of cognitive deficits following TBI. Five randomly selected DEPs were validated using ELISA in an additional 105 cases, and the results also supported the experimental findings. Conclusions. Despite limitations, our findings will facilitate further studies of the pathological mechanisms underlying TBI-induced cognitive impairment and provide new methods for the research and development of neuroprotective agents. However, further investigation on a large cohort is warranted.

23 March 2009 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Open access
XXXingui Xiong
Xingui Xiong
QLQinghua Liang
Qinghua Liang
CJChen Jiang
Chen Jiang
RFRong Fan
Rong Fan
TCTianli Cheng
Tianli Cheng
Ischemic strokes are often accompanied by serious brain injury and poor prognosis, but the molecular mechanisms of primary and secondary injury have not been fully understood. The aim of the present study was to investigate the protein profile in the rat pituitary, adrenal gland, and splenic lymphocyte using proteomics techniques, and to elucidate potential changes in the immune neuroendocrine system following cerebral ischemia injury in rats. Out of the 41 differentially expressed protein spots identified by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-MS-TOF), 13 proteins were closely related to the immune and/or the neuroendocrine system, and the other proteins might have different functions through other mechanisms in middle cerebral artery occlusion (MCAO) rats. The results showed that (i) the immune neuroendocrine system was obviously changed, and the changes might be important pathological mechanisms in brain injury after cerebral ischemia, and (ii) ischemic brain damage is co-regulated by several mechanisms. The results might lay the foundations for further research on pathological mechanisms in cerebral ischemia.